Anastomotic Leak Devices Global Market Report 2025

The anastomotic leak devices market size has grown strongly in recent years. It will grow from $3.22 billion in 2024 to $3.45 billion in 2025 at a compound annual growth rate (CAGR) of 7%. The growth during the historic period can be attributed to the expansion of clinical research and trials, increased investment in surgical safety, a rise in complex surgical procedures, the development of training programs, and an increase in the prevalence of inflammatory bowel diseases.

The anastomotic leak devices market size is expected to see strong growth in the next few years. It will grow to $4.45 billion in 2029 at a compound annual growth rate (CAGR) of 6.6%. The growth forecasted for the upcoming period can be attributed to the rising incidence of colorectal cancers, an increasing volume of gastrointestinal surgeries, a surge in surgical procedures overall, an expanding geriatric population, and a rise in lifestyle-related diseases. Key trends expected during this period include innovations in absorbable leak-prevention devices, the development of sealants and related technologies, the use of 3D printing for custom-fit stents and plugs, collaborations and licensing agreements among device manufacturers, and progress in biosensor technology.

The increasing number of surgical procedures is expected to drive the growth of the anastomotic leak devices market in the coming years. Surgical procedures involve using instruments and manual methods to treat injuries, diseases, or enhance bodily functions. This growth is fueled by advancements in minimally invasive technologies that make surgeries safer, less painful, and allow faster recovery, encouraging more patients and healthcare providers to choose surgical options. Anastomotic leak devices play a crucial role in these procedures by detecting and managing leaks at the anastomosis site, thereby reducing complications and aiding patient recovery. For example, in August 2023, The Aesthetic Society, a US-based organization for plastic surgery and cosmetic medicine, reported that Americans spent over $11.8 billion on aesthetic procedures in 2022, a 2% increase from the prior year. Hence, the rise in surgical procedures is propelling the growth of the anastomotic leak devices market.

Major companies operating in the anastomotic leak devices market are focusing on innovative solutions like 3D surgical staplers to enhance surgical outcomes in complex procedures. A 3D surgical stapler employs advanced 3D-stapling technology to create staple lines with more uniform and consistent tissue compression. This improved pressure distribution reduces the risk of leaks or bleeding at the staple line, which are critical factors in surgical safety. For example, in May 2024, Ethicon Inc., a US-based medical equipment company, launched the ECHELON LINEAR Cutter, a pioneering surgical stapler combining 3D-stapling technology with gripping surface technology (GST). This device delivers 47% fewer leaks at the staple line, thereby reducing surgical risks. It offers surgeons enhanced control and flexibility by allowing the device halves to lock or separate as needed. Designed to improve staple line integrity across various tissue types, the ECHELON LINEAR Cutter expands Ethicon’s colorectal surgical portfolio and is supported by clinical evidence demonstrating its ability to reduce complications such as anastomotic leaks, promoting safer surgeries and better patient outcomes.

In March 2024, Advanced Medical Systems Inc., a UK-based producer of advanced wound care and closure products, acquired Peters Surgical for an undisclosed sum. Through this acquisition, Advanced Medical Solutions seeks to reinforce its role as a leading global expert in tissue repair and skin closure by enhancing its product offerings, expanding its direct sales operations, and extending its global presence, leveraging the complementary expertise and distribution channels of Peters Surgical. Based in France, Peters Surgical specializes in the design, manufacturing, and distribution of medical devices primarily used in surgical procedures, including proximal anastomosis assist devices.

Major players in the anastomotic leak devices market are Johnson & Johnson, Medtronic plc, Boston Scientific Corporation, Baxter International Inc., B. Braun Melsungen AG, Olympus Corporation, Getinge AB, Ethicon Inc., Artivion Inc., Advanced Medical Solutions Group plc, Peters Surgical SAS, Dextera Surgical Inc., CryoLife Inc., GT Metabolic Solutions Inc., Synovis Micro Companies Alliance Inc., CarpoNovum AB, Colospan Ltd., Exero Medical Ltd., Lydus Medical Ltd., Ovesco Endoscopy AG, Vascular Graft Solutions Ltd., AesDex LLC.

North America was the largest region in the anastomotic leak devices market in 2024. The regions covered in anastomotic leak devices report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the anastomotic leak devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Anastomotic leak devices are medical instruments or systems created to detect, prevent, or manage leaks at the surgical junction (anastomosis) between two hollow organs, such as sections of the intestine, following gastrointestinal surgery. These leaks can cause severe complications like infection and sepsis. Such devices may consist of leak detection sensors, sealing materials, drainage systems, or stents that aid healing and preserve the anastomosis’s integrity.

The primary types of anastomotic leak devices are disposable and reusable. Disposable devices are intended for single use during surgery and are discarded afterward. They are applied in cardiovascular surgery, gastrointestinal surgery, and other areas, serving various end-users such as hospitals and specialty clinics.

The anastomotic leak devices market research report is one of a series of new reports that provides anastomotic leak devices market statistics, including anastomotic leak devices industry global market size, regional shares, competitors with an anastomotic leak devices market share, detailed anastomotic leak devices market segments, market trends and opportunities, and any further data you may need to thrive in the anastomotic leak devices industry. This anastomotic leak devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The anastomotic leak devices market consists of sales of leak detection sensors, surgical sealants, intraluminal stents, tissue reinforcement materials, and leak closure devices. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.